Medicines from Animal Cell Culture


Book Description

Medicines from Animal Cell Culture focuses on the use of animal cell culture, which has been used to produce human and veterinary vaccines, interferon, monoclonal antibodies and genetically engineered products such as tPA and erythropoietin. It also addresses the recent dramatic expansion in cell-based therapies, including the use of live cells for tissue regeneration and the culture of stem cells. Medicines from Animal Cell Culture: Provides comprehensive descriptions of methods for cell culture and nutrition as well as the technologies for the preservation and characterisation of both the cells and the derived products Describes the preparation of stem cells and others for use in cell-based therapies – an area of burgeoning research Includes experimental examples to indicate expected results Covers regulatory issues from the UK, the EU and the USA and reviews how these are developing around the world Addresses the key issues of standardisation and validation with chapters on GLP and GMP for cell culture processes Delivering insight into the exciting world of biological medicines and directions for further investigation into specific topics, Medicines from Animal Cell Culture is an essential resource for researchers and technicians at all levels using cell culture within the pharmaceutical, biotechnology and biomedical industries. It is of value to laboratory managers in these industries and to all those interested in this topic alike.




Of Interest to Visitors


Book Description




Large-Scale Mammalian Cell Culture Technology


Book Description

An interdisciplinary approach, integrating biochemistry, biology, genetics, and engineering for the effective production of protein pharmaceuticals. The volume offers a biological perspective of large-scale animal cell culture and examines diverse processing strategies, process management, regulator




Cell and Tissue Culture


Book Description

Cell and Tissue Culture: Laboratory Procedures in BiotechnologyEdited by Alan Doyle Centre for Applied Microbiology &Research, Porton Down, Salisbury, UK. and J. Bryan GriffithsScientific Consultancy & Publishing, Porton, Salisbury, UK.Cell and Tissue Culture: Laboratory Procedures in Biotechnologyintroduces the reader to animal cell culture methods describing thekey cells, core techniques, how to scale up the culture forcommercial production, and regulatory aspects. This book provideseasy to follow, step-by-step protocols, with trouble-shooting tipsand notes on time considerations. Alternative procedures,background information and references supplement the mainprocedures described. Other features include: * Experimental examples to indicate expected results; * Quick reference symbols such as safety icons with warning notes;and, * A list of suppliers is provided to allow easy access tolaboratory products. Written by a team of international scientists, Cell and TissueCulture: Laboratory Procedures in Biotechnology will be of interestto researchers, technicians and process engineers using cellculture within the biotechnology, biomedicine and pharmaceuticalindustries.




Senate Treaty Documents


Book Description




The Encyclopedia of Cell Technology


Book Description

Brings together up-to-date information on all key aspects of plant and animal cell technology in a single resource. * Covers scientific, historical, and ethical aspects of biotechnology. * Synthesizes a wealth of information in a valuable one-stop resource. * Invaluable to researchers working animal or plant cell technology.







Large-Scale Mammalian Cell Culture


Book Description

Large-Scale Mammalian Cell Culture is composed of papers presented as part of a symposium sponsored by the American Chemical Society Division of Microbial and Biochemical Technology at the 188th American Chemical Society National Meeting, held at Philadelphia, Pa., on Aug. 27, 1984. A rapid development of large-scale mammalian cell culture technology for the production of biologically important molecules becomes apparent. This book looks into this technology, its potential for commercial application, and the regulatory concerns posed by its use for the production of human therapeutics.